Brooklyn ImmunoTherapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTX and other ETFs, options, and stocks.

About BTX

Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.

CEO

Matthew Angel

CEOMatthew Angel

Employees

Employees10

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1984

Founded1984

Employees

Employees10

BTX Key Statistics

Market cap

15.26M

Market cap15.26M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

614.84K

Average volume614.84K

High today

$0.2699

High today$0.2699

Low today

$0.2246

Low today$0.2246

Open price

$0.23

Open price$0.23

Volume

405.18K

Volume405.18K

52 Week high

$10.10

52 Week high$10.10

52 Week low

$0.21

52 Week low$0.21

BTX Earnings

-$0.29

-$0.19

-$0.10

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 17, Pre-Market

ActualExpected Nov 17, Pre-Market